Skip to content

Predictive Value of Procalcitonin for Bacteremia in the ICU

Predictive Value of Procalcitonin for Bacteremia in the ICU

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03497741
Enrollment
170
Registered
2018-04-13
Start date
2017-10-01
Completion date
2019-03-01
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Procalcitonin, Sepsis

Keywords

Intensive Care Unit

Brief summary

Association between plasma procalcitonin levels and positive blood cultures in critical illness patients in the ICU.

Detailed description

Rationale: Association of procalcitonin levels and blood cultures in critical illness patients on the ICU. Objective: Procalcitonin is an acute phase protein. As part of the acute phase response, procalcitonin is produced during sepsis. Previous research shows that procalcitonin is a biomarker for bloodstream infection. However, there is still little known about the value of procalcitonin in diagnostics for micro-organism underlying a sepsis in ICU patients. In modern practice, blood cultures are taken when a patient is septic to determine the responsible micro-organism. When procalcitonin is a predictive value for bacteremia in the ICU, the number of blood cultures can be reduced. Study design: An observational cohort study intervention: for each patient in the ICU blood cultures were taken, the procalcitonin level was determined. During 6 months 150 patients will be included. Main study parameters/endpoints: this study will examine the predictive value of procalcitonin in blood cultures on the ICU.

Interventions

For each patient were blood cultures were taken, a procalcitonin level was determined

Sponsors

Rijnstate Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the ICU * Age \> 18 years

Exclusion criteria

* Hemodialysis/ Continuous Veno-Venous Hemofiltration

Design outcomes

Primary

MeasureTime frameDescription
The predictive value of procalcitonin in blood cultures on the ICU6 monthsThis study will examine the predictive value of procalcitonin on blood cultures on the ICU. A high value of procalcitonin is a predictor for bacteremia. The predictive value: procalcitonin. Primary outcome: bacteremia .

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026